SG10201608167UA - 7-{(3s,4s)-3-[(cyclopropylamino)methyl]-4-fluoropyrrolidine-1-yl}-6-fluoro-1-(2-fluoroethyl)-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid crystal - Google Patents
7-{(3s,4s)-3-[(cyclopropylamino)methyl]-4-fluoropyrrolidine-1-yl}-6-fluoro-1-(2-fluoroethyl)-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid crystalInfo
- Publication number
- SG10201608167UA SG10201608167UA SG10201608167UA SG10201608167UA SG10201608167UA SG 10201608167U A SG10201608167U A SG 10201608167UA SG 10201608167U A SG10201608167U A SG 10201608167UA SG 10201608167U A SG10201608167U A SG 10201608167UA SG 10201608167U A SG10201608167U A SG 10201608167UA
- Authority
- SG
- Singapore
- Prior art keywords
- fluoropyrrolidine
- cyclopropylamino
- dihydroquinoline
- fluoroethyl
- oxo
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2011246209 | 2011-11-10 | ||
| JP2012071739 | 2012-03-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG10201608167UA true SG10201608167UA (en) | 2016-11-29 |
Family
ID=48289529
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201401817TA SG11201401817TA (en) | 2011-11-10 | 2012-11-09 | 7-{(3s,4s)-3-[(cyclopropylamino)methyl]-4-fluoropyrrolidine-1-yl}-6-fluoro-1-(2-fluoroethyl)-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid crystal |
| SG10201608167UA SG10201608167UA (en) | 2011-11-10 | 2012-11-09 | 7-{(3s,4s)-3-[(cyclopropylamino)methyl]-4-fluoropyrrolidine-1-yl}-6-fluoro-1-(2-fluoroethyl)-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid crystal |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201401817TA SG11201401817TA (en) | 2011-11-10 | 2012-11-09 | 7-{(3s,4s)-3-[(cyclopropylamino)methyl]-4-fluoropyrrolidine-1-yl}-6-fluoro-1-(2-fluoroethyl)-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid crystal |
Country Status (16)
| Country | Link |
|---|---|
| US (3) | US9090587B2 (en) |
| EP (2) | EP2778159B1 (en) |
| JP (4) | JP5871948B2 (en) |
| KR (2) | KR20140098074A (en) |
| CN (2) | CN103930414B (en) |
| AU (1) | AU2016273899B2 (en) |
| BR (1) | BR112014010765B1 (en) |
| CA (1) | CA2855022C (en) |
| ES (2) | ES2621664T3 (en) |
| IN (1) | IN2014DN03277A (en) |
| NZ (1) | NZ623808A (en) |
| RU (2) | RU2615509C2 (en) |
| SA (1) | SA112330992B1 (en) |
| SG (2) | SG11201401817TA (en) |
| TW (1) | TWI547492B (en) |
| WO (1) | WO2013069297A1 (en) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SA112330992B1 (en) * | 2011-11-10 | 2015-09-13 | كيورين فارماسوتيكال كو.، ليمتد | Crystalline form of the 7-{(3S,4S)-3 [(cyclopropylamino)methyl]-4- fluoropyrrolidine-1-YL}-6-fluoro-1-(2-fluoroethyl)-8-methoxy-4-OXO- 1,4-dihydroquinoline-3-carboxylic acid |
| JP6349306B2 (en) * | 2013-04-25 | 2018-06-27 | 杏林製薬株式会社 | tablet |
| CA2910112C (en) | 2013-04-25 | 2021-02-16 | Kyorin Pharmaceutical Co., Ltd. | Solid pharmaceutical composition |
| CA2910121A1 (en) * | 2013-04-25 | 2014-10-30 | Kyorin Pharmaceutical Co., Ltd. | A pharmaceutical composition comprising a 1,4-dihydroquinoline carboxylic acid a cellulosic excipient and a salting-out agent |
| GB201402071D0 (en) | 2014-02-07 | 2014-03-26 | Galapagos Nv | Novel salts and pharmaceutical compositions thereof for the treatment of inflammatory disorders |
| JP6832706B2 (en) * | 2014-10-23 | 2021-02-24 | 杏林製薬株式会社 | Solid pharmaceutical composition |
| US10154993B2 (en) | 2014-10-23 | 2018-12-18 | Kyorin Pharmaceutical Co., Ltd. | Solid pharmaceutical composition |
| MY191848A (en) * | 2015-03-13 | 2022-07-18 | Kyorin Seiyaku Kk | Respiratory infection treating agent |
| US10406149B2 (en) | 2015-06-02 | 2019-09-10 | Kyorin Pharmaceutical Co., Ltd. | Aqueous liquid formulation |
| US10617684B2 (en) | 2015-06-02 | 2020-04-14 | Kyorin Pharmaceutical Co., Ltd. | Aqueous drug |
| EP3305295A4 (en) * | 2015-06-02 | 2019-02-20 | Kyorin Pharmaceutical Co., Ltd. | Aqueous drug |
| CN110891571A (en) | 2017-06-16 | 2020-03-17 | 杏林制药株式会社 | Therapeutic agent for aspiration pneumonia, lung suppuration or lung abscess |
| CN116549446A (en) | 2017-06-16 | 2023-08-08 | 杏林制药株式会社 | Therapeutic agent for aspiration pneumonia, lung suppuration or lung abscess |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA944369B (en) * | 1993-08-27 | 1995-02-13 | Hokuriku Seuyaku Co Ltd | 5-amino-8-methyl-7-pyrrolidinylquinoline-3-carboxylic acid derivative |
| CN1158846A (en) * | 1995-05-09 | 1997-09-10 | 昆山市康壮达兽药厂 | Synthesis technology of norfluxacini hydrochloride |
| US6939515B2 (en) | 2001-08-10 | 2005-09-06 | Symyx Technologies, Inc. | Apparatuses and methods for creating and testing pre-formulations and systems for same |
| AU2002236267A1 (en) * | 2002-03-08 | 2003-09-22 | Daiichi Pharmaceutical Co., Ltd. | Quinolonecarboxylic acid derivative |
| US7514451B2 (en) * | 2003-09-10 | 2009-04-07 | Kyorin Pharmaceutical Co., Ltd. | 7-(4-Substituted-3-cyclopropylaminomethyl-1 pyrrolidinyl) quinolonecarboxylic acid derivative |
| CN101003540A (en) * | 2006-01-18 | 2007-07-25 | 广州白云山制药股份有限公司广州白云山制药总厂 | Anti infectious compound and usage |
| SA112330992B1 (en) * | 2011-11-10 | 2015-09-13 | كيورين فارماسوتيكال كو.، ليمتد | Crystalline form of the 7-{(3S,4S)-3 [(cyclopropylamino)methyl]-4- fluoropyrrolidine-1-YL}-6-fluoro-1-(2-fluoroethyl)-8-methoxy-4-OXO- 1,4-dihydroquinoline-3-carboxylic acid |
-
2012
- 2012-11-07 SA SA112330992A patent/SA112330992B1/en unknown
- 2012-11-09 KR KR1020147012681A patent/KR20140098074A/en active Search and Examination
- 2012-11-09 ES ES12846895.6T patent/ES2621664T3/en active Active
- 2012-11-09 RU RU2014123567A patent/RU2615509C2/en active
- 2012-11-09 IN IN3277DEN2014 patent/IN2014DN03277A/en unknown
- 2012-11-09 WO PCT/JP2012/007195 patent/WO2013069297A1/en active Application Filing
- 2012-11-09 CN CN201280055120.0A patent/CN103930414B/en active Active
- 2012-11-09 CN CN201510329284.3A patent/CN104945375B/en active Active
- 2012-11-09 SG SG11201401817TA patent/SG11201401817TA/en unknown
- 2012-11-09 ES ES16177827T patent/ES2747303T3/en active Active
- 2012-11-09 CA CA2855022A patent/CA2855022C/en not_active Expired - Fee Related
- 2012-11-09 EP EP12846895.6A patent/EP2778159B1/en not_active Not-in-force
- 2012-11-09 RU RU2017109814A patent/RU2017109814A/en unknown
- 2012-11-09 EP EP16177827.9A patent/EP3112359B1/en not_active Not-in-force
- 2012-11-09 JP JP2013542858A patent/JP5871948B2/en active Active
- 2012-11-09 TW TW101141841A patent/TWI547492B/en active
- 2012-11-09 NZ NZ623808A patent/NZ623808A/en not_active IP Right Cessation
- 2012-11-09 SG SG10201608167UA patent/SG10201608167UA/en unknown
- 2012-11-09 US US14/352,141 patent/US9090587B2/en not_active Expired - Fee Related
- 2012-11-09 BR BR112014010765-3A patent/BR112014010765B1/en not_active IP Right Cessation
- 2012-11-09 KR KR1020197015481A patent/KR102162208B1/en active IP Right Grant
-
2015
- 2015-06-17 US US14/741,713 patent/US9328089B2/en not_active Ceased
- 2015-08-25 JP JP2015165879A patent/JP6514069B2/en active Active
-
2016
- 2016-12-14 AU AU2016273899A patent/AU2016273899B2/en not_active Ceased
-
2017
- 2017-05-08 JP JP2017092125A patent/JP6349435B2/en active Active
-
2018
- 2018-05-02 US US15/969,342 patent/USRE47785E1/en active Active
- 2018-07-13 JP JP2018132781A patent/JP6818719B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG10201608167UA (en) | 7-{(3s,4s)-3-[(cyclopropylamino)methyl]-4-fluoropyrrolidine-1-yl}-6-fluoro-1-(2-fluoroethyl)-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid crystal | |
| HK1207365A1 (en) | Carboxylic acid compounds | |
| HK1187259A1 (en) | Substituted quinoline compounds | |
| HK1203514A1 (en) | -amino acid compounds for liver isease | |
| GB2509841B (en) | Universal Arm System | |
| ZA201406639B (en) | Stabilized hypohalous acid solutions | |
| EP2604583A4 (en) | Li2O-Al2O3-SiO2-BASED CRYSTALLIZED GLASS | |
| AP4063A (en) | Dimethyl-benzoic acid compounds | |
| EP2542234A4 (en) | Methods of using (1s, 3s) -3-amino-4-difluoromethylenyl-1-cyclopentanoic acid | |
| EP2660214A4 (en) | Crystallized glass | |
| SG11201403205SA (en) | Process for making levulinic acid | |
| EP2832726A4 (en) | (2-heteroarylamino)succinic acid derivative | |
| HK1193407A1 (en) | Pyrrolidine-3-ylacetic acid derivative -3- | |
| HK1201522A1 (en) | Acetic acid ester compound or salt thereof | |
| AU2010905634A0 (en) | Processes for preparing 8-hydroxy quinoline derivatives | |
| AU2011900159A0 (en) | Process for capturing acid gases | |
| AU2011905028A0 (en) | E-trakka equine stride length system | |
| ZA201306884B (en) | Stabilized hypohalous acid solutions | |
| AU2012900017A0 (en) | Processes for preparing 8-hydroxy quinoline derivatives | |
| IL215542A0 (en) | Aerial identification system | |
| AU2011900024A0 (en) | Livestock handling system | |
| TH133949B (en) | Process for making terephthalic acid (Terephthalic acid) pure | |
| AU2012902253A0 (en) | Improved Electronic Display System | |
| AU2012903692A0 (en) | Vegetation support system | |
| AU2011900833A0 (en) | Improved Optical Aisle System |